Navigation Links
Ginkgo Biloba for Prevention of Dementia

KARLSRUHE, Germany, Nov. 18 /PRNewswire/ -- Schwabe, the manufacturer of the Ginkgo extract EGb 761(R), believes that the GEM study results do not allow a final conclusion on the potential of the extract in dementia prevention.

GEM is one of five studies that have been or are investigating the effect of standardized Ginkgo extract on the prevention of dementia. The GEM study investigated the probability of developing dementia in 3069 subjects (average age on entry 79 years) receiving either 240 mg EGb 761(R) or placebo daily. Over the 6-year treatment period, compliance fell to only 60%.

Previous results from two epidemiological studies in France showed a positive influence of EGb 761(R) on the onset of Alzheimer's and length of survival without dementia, thus raising expectations that EGb 761(R) might prove useful in this context. Earlier this year an NIH sponsored study showed a positive effect of standardized Ginkgo biloba extract on the risk of developing dementia only in those participants who took their medicine regularly. Another large scale study with EGb 761(R), the GUIDAGE study with 2854 patients aged 70 and above, is currently ongoing in France. Schwabe believes that the results of that study should be awaited before a fuller assessment of the potential of EGb 761(R) in dementia prevention can be made.

It is also important to note that the outcome of the GEM study in no way affects or detracts from the efficacy of EGb 761(R) in the treatment of manifest Alzheimer's as proven in a number of clinical studies, e.g. most recently presented at the International Conference on Alzheimer's Disease (ICAD) in Chicago in July 2008 [1]. There, EGb 761(R) was shown to improve cognition as well as neuropsychiatric symptoms and activities of daily living in dementia patients. Furthermore, it not only benefited the patients themselves but in addition provided significant relief to the care-giving relatives.

To date, there are no medications available for prevention of dementia and all attempts to demonstrate prophylactic action have so far failed. This applies to approved dementia drugs as well as to other active substances such as acetylsalicylic acid, vitamin E, hormones, or NSAIDs.

This makes it all the more important to support the cognitive performance at an appropriately early stage. EGb 761(R) has recently been shown to improve concentration as well as memory and learning ability in individuals over 45 with mild cognitive deficits [2].

About Schwabe

Dr. Willmar Schwabe Pharmaceuticals, headquartered in Karlsruhe, Germany, was founded in 1866. For more than 140 years, Schwabe Pharmaceuticals has been dedicated to providing patients and health care professionals with clinically proven herbal medicines and natural health care solutions. Today, the group is the global leader in the manufacturing of herbal medicines.


     Prof. Dr. med. Michael Habs
     Dr. Willmar Schwabe GmbH & Co. KG
     Willmar-Schwabe-Str. 4
     76227 Karlsruhe
     Telefon: (0721) 40 05-498
     Telefax: (0721) 40 05-500

    [1] Ihl R, Tribanek M, Napryeyenko O. A 240-mg Once-Daily Formulation of
        Ginkgo biloba Extract EGb 761(R) is Effective in Both Alzheimer's
        Disease and Vascular Dementia: Results from a Randomized Controlled
        Trial.  Alzheimer's & Dementia 2008;4(suppl 2):T165-T166.
    [2] Hoerr R, Grass-Kapanke B, Tribanek M, Kaschel R. Effects of Ginkgo
        biloba extract EGb 761(R) on cognition and quality of life in
        subjects with very mild cognitive impairment. International Journal
        of Psychology 2008;43:404.

SOURCE Schwabe Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ginkgo No Shield Against Alzheimers
2. Ginkgo Biloba Might Not Preserve Memory in Octogenarians
3. AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research
4. Leading Physicians To Host Medical Device Related Infection Prevention CME Webcast
5. New Health Retreat Gives a Fresh Attitude Towards Disease Prevention
6. Measles Initiative Supports Disease Prevention for Children in Chinas Earthquake Zone
7. Vitamins E and C supplements not effective for prevention of cardiovascular disease in men
8. U.S. Preventive Medicine(R) Awards Inaugural Global Prevention Prize to Dr. Valentin Fuster of Mount Sinai Heart
9. Obama's Call for "Change We Can Believe In" Makes Prevention a Priority in Health Reform
10. Nov. 10 Webinar on Dementia Prevention in Senior Communities to Discuss Brain Fitness Programming with UCLAs Dr. Gary Small
11. North Dakota Votes to Keep Promise to Kids by Fully Funding Tobacco Prevention
Post Your Comments:
(Date:10/13/2017)... ... 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board of ... Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve ... Puffer’s retirement at the end of 2018. Upon assuming the role of President and ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
Breaking Medicine Technology: